-
Loading metrics
Targeted Silencing of Elongation Factor 2 Kinase Suppresses Growth and Sensitizes Tumors to Doxorubicin in an Orthotopic Model of Breast Cancer
- Ibrahim Tekedereli,
- S. Neslihan Alpay,
- Clint D. J. Tavares,
- Zehra E. Cobanoglu,
- Tamer S. Kaoud,
- Ibrahim Sahin,
- Anil K. Sood,
- Gabriel Lopez-Berestein,
- Kevin N. Dalby,
- Bulent Ozpolat
x
- Published: July 20, 2012
- https://doi.org/10.1371/journal.pone.0041171